In updated guidance posted on its website over the weekend, the U.S. Centers for Disease Control and Prevention acknowledged an inability to accurately determine if individuals had been infected with Covid-19 via antibody tests; if the test is used in a population where prevalence is low, it's possible that "less than half of those testing positive will truly have antibodies."
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,